Michael John Sumner - 30 Jun 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Medical Officer
Signature
/s/ Michael John Sumner
Issuer symbol
INO
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
03 Jul 2023, 17:12:48 UTC
Previous filing
17 May 2023
Next filing
28 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +35,000 35,000 30 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -35,000 -33% $0.000000 70,000 30 Jun 2023 Common Stock 35,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.